Switzerland
eCO2 is a company that has been serving the pharmaceutical industry since its establishment in 1998. Specializing in constructing high-pressure systems, eCO2 is dedicated to meeting the most challenging needs of its clients. The company offers a wide range of services including expertise in the design and development of high-pressure processes, retrofitting high-pressure plants, creating pilot plants, and delivering precision cleaning services.
With a strong focus on innovation, eCO2 has been able to carve out a niche for itself in the pharmaceutical industry. As of now, there is no public information available about the company's headquarter location, past investments, or the names of any previous investors.
Given the specialized nature of its services, eCO2 presents an interesting opportunity for venture capital firms looking to invest in companies that cater to the unique needs of the pharmaceutical industry. Its track record and expertise in high-pressure systems make eCO2 a potential candidate for strategic investments aimed at furthering its growth and capabilities.
